BridgeMD
Prevention study for Multiple Myeloma
Official title Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
ClinicalTrials.gov ID: NCT07044427
What this study is testing
- What it's testing
- Approximately one third of the population over the age of 65 falls at least once a year. The risk of falling is in increased in older patients with tumor diseases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy)
- ECOG status ≤ 3
- Age ≥18 years
- Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits
- Ability to give informed consent
You likely can't join if
- Any physical or mental limitations that would prevent participation in the training program or the planned follow-up checks.
See the full eligibility criteria
- Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy)
- ECOG status ≤ 3
- Age ≥18 years
- Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits
- Ability to give informed consent
- Written consent to participate in the study
- Sufficient written and spoken German to complete the questionnaire
- Any physical or mental limitations that would prevent participation in the training program or the planned follow-up checks.
The study team makes the final eligibility decision.
Where it's taking place
- Heidelberg, Baden Würtemberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Heidelberg, Baden Würtemberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.